DrugJun 2, 2021
Triumeq recall — FDA D-0486-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
Recall history in this database
Classification mix: Class II: 57, Class I: 7.
DrugJun 2, 2021
Spiriva HandiHaler recall — FDA D-0453-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodium, 28 recall — FDA D-0403-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Cardinal Health Belsomra (suvorexant) tablets 10 mg Each tablet contains 10 mg suvorexant recall — FDA D-0522-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Cardinal Health Ferrous Sulfate 75 mg (equivalent to 15 mg Iron) Per 1.0 mL Alcohol 0.2% v/v recall — FDA D-0504-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Desvenlafaxine Extended-Release Tablets 25 mg 30 Tablets recall — FDA D-0581-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Chantix (varenicline) Tablets Starting Pack Contains: 1 Starting Week (0.5 mgx11 tablets) 3 recall — FDA D-0556-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Steglatro (ertugliflozin) tablets 15 mg 30 Tablets recall — FDA D-0524-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Narcan (naloxone HCl) Nasal Spray 4 mg Two Pack This box contains two (2) 4-mg doses of recall — FDA D-0473-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Trelegy Ellipta recall — FDA D-0482-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Auryxia (ferric citrate) tablets 210 mg* 200 Tablets recall — FDA D-0499-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Rectiv (nitroglycerin) Ointment 0.4% For Intra-anal Use Only 30 g recall — FDA D-0419-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Lamotrigine Extended-Release Tablets 250 mg 30 Tablets recall — FDA D-0538-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Chantix (varenicline) Tablets Continuing Month Box Contains: 4 Continuing Weeks recall — FDA D-0555-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Cardinal Health Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser recall — FDA D-0462-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Cardinal Health FaBB Vitamin B6 recall — FDA D-0488-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Cardinal Health Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan recall — FDA D-0596-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Oseltamivir Phosphate for Oral Suspension 6 mg/mL* *Each mL contains 6 mg oseltamivir base recall — FDA D-0423-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg 30 Tablets recall — FDA D-0509-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
edarbyclor Azilsartan Medoxomil and Chlorthalidone Tablets 40 mg*/25 mg *Each tablet recall — FDA D-0431-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Cardinal Health Timolol Maleate Ophthalmic Solution, USP 0.5% 2.5 mL Sterile For Topical recall — FDA D-0428-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Theophylline (Anhydrous) Extended-Release Tablets 400 mg 100 Tablets recall — FDA D-0485-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Balziva 28 Day recall — FDA D-0579-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
DrugJun 2, 2021
Trokendi XR (topiramate) extended-release capsules 100 mg 30 Capsules recall — FDA D-0570-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class IIFDA: TerminatedCardinal Health Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Cardinal Health Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.